Bellicum Pharmaceuticals, Inc. Made Headway
Wed, Nov 22, 2023 at 07:28 PM
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) shot up at $0.22, a gain of 67.2%. On Wed, Nov 22, 2023, BLCM:NASDAQ touched a New 2-Week High of $0.22. From Wed, Nov 08, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.
Top 10 Gainers:
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 143.44%
- AgileThought Inc. (AGIL:NASDAQ), 137.35%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 104.08%
- USD Partners LP (USDP:NYSE), 103.58%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 67.16%
- Marpai Inc. (MRAI:NASDAQ), 43.45%
- MoneyHero Limited (MNY:NASDAQ), 40.28%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 38.46%
- POET Technologies Inc. (POET:NASDAQ), 35%
- AquaBounty Technologies, Inc. (AQB:NASDAQ), 33.54%